This content is PDF only. Please click on the PDF icon to access.
It is apparent to most students of psychiatric therapies that the second psychopharmacologic drug revolution is not imminent. In fact there have been almost no significant drug "breakthroughs" in psychopharmacology since the 1950s, which witnessed the introduction of the antipsychotics (phenothiazines), the antidepressants (monoamine oxidase inhibitors and tricyclics), and the antianxiety agents (meprobamate and benzodiazepines). Despite more than 10 years of widespread clinical use, it is disconcerting that these agents continue to be used inappropriately, irrationally, and excessively by clinicians including specialists and even many psychiatrists. This has resulted in these drug's, which regulate man's emotions and behavior, outselling any
Practical Clinical Psychopharmacology.. Ann Intern Med. 1975;82:129–130. doi: https://doi.org/10.7326/0003-4819-82-1-129_4
Download citation file:
Published: Ann Intern Med. 1975;82(1):129-130.
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use